Impact of lung transplantation on serum lipids in COPD

Respiratory Medicine

Volumn 105, Issue 12, 2011, Pages 1961-1968

  Reed, Robert M ^a   Hashmi, Salman ^a   Eberlein, Michael ^b,c   Iacono, Aldo ^a   Netzer, Giora ^a   Defilippis, Andrew ^b   Girgis, Reda E ^b   Toth, Peter P ^d,e   Scharf, Steven ^a   Jones, Steven ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF ILLINOIS   (United States)

^e Preventive Cardiology   (United States)

Author keywords

Cholesterol; COPD; HDL; Lipoproteins; Lung transplantation

Indexed keywords

CYCLOSPORIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; TRIACYLGLYCEROL;

AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRIACYLGLYCEROL BLOOD LEVEL;

CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; TACROLIMUS; TRIGLYCERIDES;

EID: 81155137877     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2011.10.003     Document Type: Article

References (35)

1. R.J. Halbert, S. Isonaka, D. George, and A. Iqbal Interpreting COPD prevalence estimates: what is the true burden of disease? Chest 123 5 2003 1684 1692 (Pubitemid 36549792)
2. J.D. Christie, L.B. Edwards, A.Y. Kucheryavaya, P. Aurora, F. Dobbels, and R. Kirk The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report-2010 J Heart Lung Transplant 29 10 2010 1104 1118
3. J. Finkelstein, E. Cha, and S.M. Scharf Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity Int J Chron Obstruct Pulmon Dis 4 2009 337 349
4. L. Huiart, P. Ernst, and S. Suissa Cardiovascular morbidity and mortality in COPD Chest 128 4 2005 2640 2646 (Pubitemid 41507622)
5. D.D. Sin, and S.F. Man Impact of cancers and cardiovascular diseases in chronic obstructive pulmonary disease Curr Opin Pulm Med 14 2 2008 115 121 (Pubitemid 351323162)
6. R.M. Jindal Post-transplant hyperlipidaemia Postgrad Med J 73 866 1997 785 793 (Pubitemid 27526761)
7. R.M. Reed, A. Iacono, A. Defilippis, M. Eberlein, R.E. Girgis, and S. Jones Advanced chronic obstructive pulmonary disease is associated with high levels of high-density lipoprotein cholesterol J Heart Lung Transplant 2011
8. G.M. Tisi, A. Conrique, E. Barrett-Connor, and S.M. Grundy Increased high density lipoprotein cholesterol in obstructive pulmonary disease (predominant emphysematous type) Metabolism 30 4 1981 340 346 (Pubitemid 11101146)
9. C.M. Ballantyne, B. Radovancevic, J.A. Farmer, O.H. Frazier, L. Chandler, and C. Payton-Ross Hyperlipidemia after heart transplantation: report of a 6-year experience, with treatment recommendations J Am Coll Cardiol 19 6 1992 1315 1321
10. M. Cassader, G. Ruiu, R. Gambino, N. Alemanno, G. Triolo, and F. Veglia Lipoprotein-apolipoprotein changes in renal transplant recipients Lipids 37 10 2002 967 974 (Pubitemid 36026492)
11. J.A. Farmer, C.M. Ballantyne, O.H. Frazier, B. Radovancevic, C. Payton-Ross, and W. Patsch Lipoprotein(a) and apolipoprotein changes after cardiac transplantation J Am Coll Cardiol 18 4 1991 926 930
12. R.M. Jindal, I. Popescu, S. Emre, M.E. Schwartz, P. Boccagni, and P. Meneses Serum lipid changes in liver transplant recipients in a prospective trial of cyclosporine versus FK506 Transplantation 57 9 1994 1395 1398 (Pubitemid 24145590)
13. E.F. Nash, A. Stephenson, E.J. Helm, P.R. Durie, E. Tullis, and L.G. Singer Impact of lung transplantation on serum lipids in adults with cystic fibrosis J Heart Lung Transplant 2010
14. B.A. Johnson, A.T. Iacono, A. Zeevi, K.R. McCurry, and S.R. Duncan Statin use is associated with improved function and survival of lung allografts Am J Respir Crit Care Med 167 9 2003 1271 1278 (Pubitemid 36555101)
15. W.H. Ettinger Jr. , and W.R. Hazzard Prednisone increases very low density lipoprotein and high density lipoprotein in healthy men Metabolism 37 11 1988 1055 1058
16. M.R. Taskinen, T. Kuusi, H. Yki-Jarvinen, and E.A. Nikkila Short-term effects of prednisone on serum lipids and high density lipoprotein subfractions in normolipidemic healthy men J Clin Endocrinol Metab 67 2 1988 291 299
17. J. Zimmerman, M. Fainaru, and S. Eisenberg The effects of prednisone therapy on plasma lipoproteins and apolipoproteins: a prospective study Metabolism 33 6 1984 521 526 (Pubitemid 14119897)
18. A.N. Georgiadis, E.C. Papavasiliou, E.S. Lourida, Y. Alamanos, C. Kostara, and A.D. Tselepis Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment-a prospective, controlled study Arthritis Res Ther 8 3 2006 R82
19. J.P. Girod, and D.J. Brotman Does altered glucocorticoid homeostasis increase cardiovascular risk? Cardiovasc Res 64 2 2004 217 226 (Pubitemid 39361682)
20. W. Macnee Pathogenesis of chronic obstructive pulmonary disease Clin Chest Med 28 3 2007 479 - 13, v. (Pubitemid 47284592)
21. R. Vikstedt, D. Ye, J. Metso, R.B. Hildebrand, T.J. Van Berkel, and C. Ehnholm Macrophage phospholipid transfer protein contributes significantly to total plasma phospholipid transfer activity and its deficiency leads to diminished atherosclerotic lesion development Arterioscler Thromb Vasc Biol 27 3 2007 578 586
22. X.C. Jiang, J. D'Armiento, R.K. Mallampalli, J. Mar, S.F. Yan, and M. Lin Expression of plasma phospholipid transfer protein mRNA in normal and emphysematous lungs and regulation by hypoxia J Biol Chem 273 25 1998 15714 15718 (Pubitemid 28298190)
23. M.C. Cheung, G. Wolfbauer, B.G. Brown, and J.J. Albers Relationship between plasma phospholipid transfer protein activity and HDL subclasses among patients with low HDL and cardiovascular disease Atherosclerosis 142 1 1999 201 205 (Pubitemid 28551826)
24. J. Li, L.N. Thorne, N.M. Punjabi, C.K. Sun, A.R. Schwartz, and P.L. Smith Intermittent hypoxia induces hyperlipidemia in lean mice Circ Res 97 7 2005 698 706 (Pubitemid 41416339)
25. A.N. Tin'kov, and V.A. Aksenov Effects of intermittent hypobaric hypoxia on blood lipid concentrations in male coronary heart disease patients High Alt Med Biol 3 3 2002 277 282
26. H.J. Pownall, D. Hickson-Bick, and J.B. Massey Effects of hydrophobicity on turnover of plasma high density lipoproteins labeled with phosphatidylcholine ethers in the rat J Lipid Res 32 5 1991 793 800
27. A.R. Tall, E. Abreu, and J. Shuman Separation of a plasma phospholipid transfer protein from cholesterol ester/phospholipid exchange protein J Biol Chem 258 4 1983 2174 2180 (Pubitemid 13118414)
28. T.A. Voyno-Yasenetskaya, L.G. Dobbs, S.K. Erickson, and R.L. Hamilton Low density lipoprotein- and high density lipoprotein-mediated signal transduction and exocytosis in alveolar type II cells Proc Natl Acad Sci U S A 90 9 1993 4256 4260 (Pubitemid 23134205)
29. J. Hohlfeld, H. Fabel, and H. Hamm The role of pulmonary surfactant in obstructive airways disease Eur Respir J 10 2 1997 482 491 (Pubitemid 27063872)
30. W. Janssens, R. Bouillon, B. Claes, C. Carremans, A. Lehouck, and I. Buysschaert Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene Thorax 65 3 2010 215 220
31. L. Chishimba, D.R. Thickett, R.A. Stockley, and A.M. Wood The vitamin D axis in the lung: a key role for vitamin D-binding protein Thorax 65 5 2010 456 462
32. J. Auwerx, R. Bouillon, and H. Kesteloot Relation between 25-hydroxyvitamin D3, apolipoprotein A-I, and high density lipoprotein cholesterol Arterioscler Thromb 12 6 1992 671 674
33. W.P. Castelli Cholesterol and lipids in the risk of coronary artery disease-the Framingham Heart Study Can J Cardiol 4 Suppl A 1988 5A 10A
34. P.P. Toth When high is low: raising low levels of high-density lipoprotein cholesterol Curr Cardiol Rep 10 6 2008 488 496
35. D.J. Gordon, J.L. Probstfield, R.J. Garrison, J.D. Neaton, W.P. Castelli, and J.D. Knoke High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies Circulation 79 1 1989 8 15 (Pubitemid 19043669)